All News

For patients with HRRm prostate cancer receiving Akeega and Zytiga with prednisone, quality of life remained at baseline.

Ponsegromab improved body weight, suppressed GDF-15 and was well-tolerated over 64 weeks in cancer-associated cachexia, including patients switching from placebo.

Adding Kisqali to a nonsteroidal aromatase inhibitor continued to reduce recurrence risk and improve survival at five years in early breast cancer.

Among patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma that is resectable, Imfinzi with FLOT improved survival.

Adding Imfinzi to Bacillus Calmette-Guérin therapy improved disease-free survival for patients with high-risk, non-muscle invasive bladder cancer.

Among patients with muscle-invasive bladder cancer, perioperative Imfinzi to chemotherapy doesn’t have a detrimental effect on patient-reported outcomes.

Lenvima and Keytruda with chemo did not help patients with metastatic esophageal squamous cell carcinoma live longer than Keytruda and chemotherapy alone.

Sevabertinib showed high response rates and durable disease control in patients with HER2-mutant NSCLC, with diarrhea as the main manageable side effect.

Home-based supervised physical activity has no major impact on fatigue and quality of life for patients with metastatic cancer receiving oral targeted therapy.

The addition of Tecentriq to BCG therapy did not significantly improve outcomes for patients with non–muscle-invasive bladder versus BCG alone.

Stephanie Wachtel told CURE that areola tattooing after HER2-positive breast cancer helped her feel whole again and reconnect with her creativity.

LiveLung, a nonprofit organization, invites the CSRA’s lung cancer community to its educational meeting.

Artificial intelligence (AI) is revolutionizing the way cancer is studied and treated.

Registration is now open for the National Caregivers Self-Care and Tools online educational event on November 7th, 2025 at 11AM Pacific Time.

Between paying for treatment, managing a reduced income, and understanding insurance, the financial side of cancer can feel overwhelming.

After decades of lymphedema, breast cancer survivor Nora Ambros finds relief through robot-assisted microsurgery at Hackensack University.

Paper Describes Successful Genetic Testing Program Offered at Sheila R. Veloz Breast Center

During her radiation treatments, Sister Monica Marcinak found grace, humor and deep compassion among fellow patients and caregivers facing cancer together.

For patients with pancreatic cancer, this is a guide to the basics you need to know about this disease.

This patient guide explains gastrointestinal stromal tumors, covering diagnosis, treatment options, targeted therapies and practical care tips.

Supportive care with ESAs or danazol alongside Jakafi helps myelofibrosis patients with anemia manage symptoms and maintain effective treatment doses.

The FDA granted orphan drug designation to the investigational therapy MNV-201 for myelodysplastic syndrome, a serious, age-related blood disorder.

I view Breast Cancer Awareness Month as a time to share hope, connection, and stories that remind others life after cancer is possible.

Dr. Anjana Pillai explains that staging liver cancer involves assessing tumor size, spread, and vessel involvement to guide treatment.

When reflecting on the Japanese art of kintsugi, one can find inspiration during a cancer journey, as CURE columnist Chester Freeman explained.

Dr. Anjana Pillai explains liver cancer types, risk factors, and prevention, stressing early screening for high-risk patients with liver disease.

Addressing spirituality and religion can potentially help patients with gynecologic cancers, researchers have found.

After treatment for follicular lymphoma, I reflect on how cancer, retirement, and loss reshaped my sense of normal and what life looks like now.